Back to the main directory
Currency
- S4ME: Q1 2021 DiaSorin SpA Earnings Call by BNP Paribas
- S4ME: Motus GI Holdings, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: Park Lawn Corporation Interim financial statements/report - English 2021-03-31 by BNP Paribas
- S4ME: Manning&Napier, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: Eledon Pharmaceuticals, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: BIOLIFE SOLUTIONS INC 8-K 2021-05-13 by BNP Paribas
- S4ME: CYNERGISTEK, INC 10-Q 2021-03-31 by BNP Paribas
- S4ME: MARRONE BIO INNOVATIONS INC 8-K 2021-05-13 by BNP Paribas
- S4ME: Power Financial Corporation Interim financial statements/report - English 2021-03-31 by BNP Paribas
- S4ME: Assure Holdings Corp. 8-K 2021-05-14 by BNP Paribas
- S4ME: GALAXY NEXT GENERATION, INC. 10-Q 2021-03-31 by BNP Paribas
- S4ME: HARVEST HEALTH&RECREATION INC. 10-Q 2021-03-31 by BNP Paribas
- S4ME: China Gold International Resources Corp. Ltd. MD&A - English 2021-03-31 by BNP Paribas
- S4ME: Simpson Manufacturing Co., Inc. 8-K 2021-05-14 by BNP Paribas
- S4ME: Cidara Therapeutics, Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: ASENSUS SURGICAL, INC. 8-K 2021-11-05 by BNP Paribas
- S4ME: Achieve Life Sciences, Inc. Interim financial statements/report - English 2021-03-31 by BNP Paribas
- S4ME: Forma Therapeutics Holdings, Inc. 8-K 2021-05-14 by BNP Paribas
- S4ME: EVOLVING SYSTEMS INC 10-Q 2021-03-31 by BNP Paribas
- S4ME: Cidara Therapeutics, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: Apria, Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: GENKYOTEX SA Prelim Q1 2021-03-31 by BNP Paribas
- S4ME: Regulus Therapeutics Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: AgroFresh Solutions, Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: LifeMD, Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: CV Sciences, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: AbCellera Biologics Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: GLADSTONE CAPITAL CORP 8-K 2021-05-13 by BNP Paribas
- S4ME: IZEA Worldwide, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: AVROBIO, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: PROGENITY, INC. 10-Q 2021-03-31 by BNP Paribas
- S4ME: Vireo Health International, Inc. (formerly Darien Business Development Corp.) MD&A - English ... by BNP Paribas
- S4ME: SPECTRUM PHARMACEUTICALS INC 8-K 2021-05-13 by BNP Paribas
- S4ME: Boxlight Corp 10-Q 2021-03-31 by BNP Paribas
- S4ME: INFINITY PHARMACEUTICALS, INC. 8-K 2021-05-13 by BNP Paribas
- S4ME: GERON CORP 8-K 2021-11-05 by BNP Paribas
- S4ME: DIASORIN S.P.A. Prelim Q1 2021-03-31 by BNP Paribas
- S4ME: BSQUARE CORP /WA 10-Q 2021-03-31 by BNP Paribas
- S4ME: NorthWest Healthcare Properties Real Estate Investment Trust Interim financial statements/report ... by BNP Paribas
- S4ME: iTeos Therapeutics, Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: Ovid Therapeutics Inc. 10-Q 2021-03-31 by BNP Paribas
- S4ME: DYADIC INTERNATIONAL INC 8-K 2021-05-13 by BNP Paribas
- S4ME: Blink Charging Co. 8-K 2021-05-13 by BNP Paribas
- S4ME: D&L INDUSTRIES INC. Interim Q1 2021-03-31 by BNP Paribas
- S4ME: KEMPHARM, INC 10-Q 2021-03-31 by BNP Paribas
- S4ME: NAVIDEA BIOPHARMACEUTICALS, INC. 10-Q 2021-03-31 by BNP Paribas
- S4ME: ProPhase Labs, Inc. 8-K 2021-05-13 by BNP Paribas
- S4ME: SVB FINANCIAL GROUP 8-K 2021-12-05 by BNP Paribas
- S4ME: LEAP THERAPEUTICS, INC. 8-K 2021-05-14 by BNP Paribas
- S4ME: Repare Therapeutics Inc. 8-K 2021-05-13 by BNP Paribas